The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class… The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class…

NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction



Zach Anderson
Nov 04, 2025 20:41

NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries.

NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress.

Transforming Structure Prediction

The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline.

Technological Advancements

The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally.

Practical Applications and Deployment

OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results.

Open Science and Enterprise Reliability

The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class 1 open-source system, it ensures transparency and reproducibility.

Federated Learning and Global Collaboration

OpenFold3 has proven its capability to scale across global R&D environments through secure federated workflows validated by Apheris and SandboxAQ. This allows partners to fine-tune models on proprietary data without sharing sensitive datasets, maintaining regulatory compliance while enhancing model performance with diverse datasets.

The Future of Protein AI

OpenFold3 represents more than just a technological advancement; it is a foundation for future developments in protein AI. By converging open-source science, accelerated computing, and federated collaboration, it ensures that the tools used by global researchers meet enterprise standards for reliability and security.

Image source: Shutterstock

Source: https://blockchain.news/news/nvidia-openfold3-nim-advancing-biomolecular-prediction

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trading time: Tonight, the US GDP and the upcoming non-farm data will become the market focus. Institutions are bullish on BTC to $120,000 in the second quarter.

Trading time: Tonight, the US GDP and the upcoming non-farm data will become the market focus. Institutions are bullish on BTC to $120,000 in the second quarter.

Daily market key data review and trend analysis, produced by PANews.
Share
PANews2025/04/30 13:50
Who’s Building the Next Phase of Artificial Intelligence? 20 Innovators Shaping the AI Industry in 2026

Who’s Building the Next Phase of Artificial Intelligence? 20 Innovators Shaping the AI Industry in 2026

Artificial intelligence, the center of global investing in 2025, is evolving from an experimental phase. After a few volatile years – characterized by rapid model
Share
AI Journal2025/12/19 05:58
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56